Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
20.68
+0.08 (0.39%)
At close: Apr 2, 2026, 4:00 PM EDT
20.78
+0.10 (0.48%)
After-hours: Apr 2, 2026, 7:48 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$1,733,896
Market Cap
2.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| ADMA Biologics | 647 |
| Galapagos NV | 558 |
| Agios Pharmaceuticals | 540 |
| Viridian Therapeutics | 252 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
| Stoke Therapeutics | 170 |
DFTX News
- 5 days ago - New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States - Business Wire
- 6 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 10 days ago - Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 - Business Wire
- 5 weeks ago - Definium Therapeutics, Inc. (DFTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates - Business Wire
- 5 weeks ago - Definium Therapeutics to Participate at Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Business Wire
- 2 months ago - Definium Therapeutics Appoints Roger Adsett to Board of Directors - Business Wire